MWG Biotech to Supply Pfizer with Sequencing Services, Arrays, Oligos | GenomeWeb

NEW YORK, March 24 (GenomeWeb News) - MWG Biotech will supply Pfizer with sequencing services, microarrays, and oligonucleotides, the company said today.

 

Under a new worldwide framework agreement, MWG Biotech of Ebersberg, Germany, will be Pfizer's "Partner of Choice" for these products and services. The agreement is non-exclusive and unlimited, according to an MWG spokeswoman.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.